水痘帯状疱疹ウイルス（VZV）治療の世界市場（～2026年）

• 英文タイトル：Global Varicella-Zoster Virus (VZV) Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04978
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は水痘帯状疱疹ウイルス（VZV）治療のグローバル市場について調査・分析したレポートです。種類別（アシクロビル、バラシクロビル、ファムシクロビル、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別水痘帯状疱疹ウイルス（VZV）治療の競争状況、市場シェア
・世界の水痘帯状疱疹ウイルス（VZV）治療市場：種類別市場規模 2015年-2020年（アシクロビル、バラシクロビル、ファムシクロビル、その他）
・世界の水痘帯状疱疹ウイルス（VZV）治療市場：種類別市場規模予測 2021年-2026年（アシクロビル、バラシクロビル、ファムシクロビル、その他）
・世界の水痘帯状疱疹ウイルス（VZV）治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局）
・世界の水痘帯状疱疹ウイルス（VZV）治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局）
・北米の水痘帯状疱疹ウイルス（VZV）治療市場分析：米国、カナダ
・ヨーロッパの水痘帯状疱疹ウイルス（VZV）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの水痘帯状疱疹ウイルス（VZV）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の水痘帯状疱疹ウイルス（VZV）治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの水痘帯状疱疹ウイルス（VZV）治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Roche、Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Sanofi、Eli Lilly、Astrazeneca、Johnson & Johnson
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Varicella-Zoster Virus (VZV) Treatment Market
The global Varicella-Zoster Virus (VZV) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Varicella-Zoster Virus (VZV) Treatment Scope and Market Size
Varicella-Zoster Virus (VZV) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Varicella-Zoster Virus (VZV) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Roche
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson

Market segment by Type, the product can be split into
Acyclovir
Valacyclovir
Famciclovir
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Varicella-Zoster Virus (VZV) Treatment Revenue
1.4 Market by Type
1.4.1 Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acyclovir
1.4.3 Valacyclovir
1.4.4 Famciclovir
1.4.5 Others
1.5 Market by Application
1.5.1 Global Varicella-Zoster Virus (VZV) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Varicella-Zoster Virus (VZV) Treatment Market Perspective (2015-2026)
2.2 Global Varicella-Zoster Virus (VZV) Treatment Growth Trends by Regions
2.2.1 Varicella-Zoster Virus (VZV) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Varicella-Zoster Virus (VZV) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Varicella-Zoster Virus (VZV) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Varicella-Zoster Virus (VZV) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Varicella-Zoster Virus (VZV) Treatment Players by Market Size
3.1.1 Global Top Varicella-Zoster Virus (VZV) Treatment Players by Revenue (2015-2020)
3.1.2 Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Varicella-Zoster Virus (VZV) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Varicella-Zoster Virus (VZV) Treatment Market Concentration Ratio
3.2.1 Global Varicella-Zoster Virus (VZV) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Varicella-Zoster Virus (VZV) Treatment Revenue in 2019
3.3 Varicella-Zoster Virus (VZV) Treatment Key Players Head office and Area Served
3.4 Key Players Varicella-Zoster Virus (VZV) Treatment Product Solution and Service
3.5 Date of Enter into Varicella-Zoster Virus (VZV) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Varicella-Zoster Virus (VZV) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020)
5.2 Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size (2015-2020)
6.2 Varicella-Zoster Virus (VZV) Treatment Key Players in North America (2019-2020)
6.3 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020)
6.4 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size (2015-2020)
7.2 Varicella-Zoster Virus (VZV) Treatment Key Players in Europe (2019-2020)
7.3 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020)
7.4 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020)

8 China
8.1 China Varicella-Zoster Virus (VZV) Treatment Market Size (2015-2020)
8.2 Varicella-Zoster Virus (VZV) Treatment Key Players in China (2019-2020)
8.3 China Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020)
8.4 China Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Varicella-Zoster Virus (VZV) Treatment Market Size (2015-2020)
9.2 Varicella-Zoster Virus (VZV) Treatment Key Players in Japan (2019-2020)
9.3 Japan Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020)
9.4 Japan Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size (2015-2020)
10.2 Varicella-Zoster Virus (VZV) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020)

11 India
11.1 India Varicella-Zoster Virus (VZV) Treatment Market Size (2015-2020)
11.2 Varicella-Zoster Virus (VZV) Treatment Key Players in India (2019-2020)
11.3 India Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020)
11.4 India Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Varicella-Zoster Virus (VZV) Treatment Market Size (2015-2020)
12.2 Varicella-Zoster Virus (VZV) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Varicella-Zoster Virus (VZV) Treatment Introduction
13.1.4 Roche Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Varicella-Zoster Virus (VZV) Treatment Introduction
13.2.4 Merck Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Varicella-Zoster Virus (VZV) Treatment Introduction
13.3.4 Pfizer Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Varicella-Zoster Virus (VZV) Treatment Introduction
13.4.4 Novartis Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview
13.5.3 Abbott Varicella-Zoster Virus (VZV) Treatment Introduction
13.5.4 Abbott Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview
13.6.3 GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Introduction
13.6.4 GlaxoSmithKline Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Varicella-Zoster Virus (VZV) Treatment Introduction
13.7.4 Sanofi Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Eli Lilly
13.8.1 Eli Lilly Company Details
13.8.2 Eli Lilly Business Overview
13.8.3 Eli Lilly Varicella-Zoster Virus (VZV) Treatment Introduction
13.8.4 Eli Lilly Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020)
13.8.5 Eli Lilly Recent Development
13.9 Astrazeneca
13.9.1 Astrazeneca Company Details
13.9.2 Astrazeneca Business Overview
13.9.3 Astrazeneca Varicella-Zoster Virus (VZV) Treatment Introduction
13.9.4 Astrazeneca Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020)
13.9.5 Astrazeneca Recent Development
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Details
13.10.2 Johnson & Johnson Business Overview
13.10.3 Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Introduction
13.10.4 Johnson & Johnson Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020)
13.10.5 Johnson & Johnson Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Varicella-Zoster Virus (VZV) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Varicella-Zoster Virus (VZV) Treatment Revenue
Table 3. Ranking of Global Top Varicella-Zoster Virus (VZV) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acyclovir
Table 6. Key Players of Valacyclovir
Table 7. Key Players of Famciclovir
Table 8. Key Players of Others
Table 9. Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2015-2020)
Table 13. Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Varicella-Zoster Virus (VZV) Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Varicella-Zoster Virus (VZV) Treatment Players
Table 20. Global Varicella-Zoster Virus (VZV) Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Players (2015-2020)
Table 22. Global Top Varicella-Zoster Virus (VZV) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella-Zoster Virus (VZV) Treatment as of 2019)
Table 23. Global Varicella-Zoster Virus (VZV) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Varicella-Zoster Virus (VZV) Treatment Product Solution and Service
Table 26. Date of Enter into Varicella-Zoster Virus (VZV) Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Varicella-Zoster Virus (VZV) Treatment Market Size Share by Type (2015-2020)
Table 30. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Varicella-Zoster Virus (VZV) Treatment Market Size Share by Application (2015-2020)
Table 32. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Varicella-Zoster Virus (VZV) Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Varicella-Zoster Virus (VZV) Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Varicella-Zoster Virus (VZV) Treatment Market Share (2019-2020)
Table 36. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2015-2020)
Table 38. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Varicella-Zoster Virus (VZV) Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Varicella-Zoster Virus (VZV) Treatment Market Share (2019-2020)
Table 42. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2015-2020)
Table 44. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Varicella-Zoster Virus (VZV) Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Varicella-Zoster Virus (VZV) Treatment Market Share (2019-2020)
Table 48. China Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2015-2020)
Table 50. China Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Varicella-Zoster Virus (VZV) Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Varicella-Zoster Virus (VZV) Treatment Market Share (2019-2020)
Table 54. Japan Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2015-2020)
Table 56. Japan Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Varicella-Zoster Virus (VZV) Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Varicella-Zoster Virus (VZV) Treatment Market Share (2019-2020)
Table 60. Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Varicella-Zoster Virus (VZV) Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Varicella-Zoster Virus (VZV) Treatment Market Share (2019-2020)
Table 66. India Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2015-2020)
Table 68. India Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Varicella-Zoster Virus (VZV) Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Varicella-Zoster Virus (VZV) Treatment Market Share (2019-2020)
Table 72. Central & South America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2015-2020)
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Product
Table 79. Roche Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020) (Million US$)
Table 80. Roche Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Product
Table 84. Merck Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020) (Million US$)
Table 85. Merck Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Product
Table 89. Pfizer Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020) (Million US$)
Table 90. Pfizer Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Product
Table 94. Novartis Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020) (Million US$)
Table 95. Novartis Recent Development
Table 96. Abbott Company Details
Table 97. Abbott Business Overview
Table 98. Abbott Product
Table 99. Abbott Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020) (Million US$)
Table 100. Abbott Recent Development
Table 101. GlaxoSmithKline Company Details
Table 102. GlaxoSmithKline Business Overview
Table 103. GlaxoSmithKline Product
Table 104. GlaxoSmithKline Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020) (Million US$)
Table 105. GlaxoSmithKline Recent Development
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Product
Table 109. Sanofi Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020) (Million US$)
Table 110. Sanofi Recent Development
Table 111. Eli Lilly Business Overview
Table 112. Eli Lilly Product
Table 113. Eli Lilly Company Details
Table 114. Eli Lilly Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020) (Million US$)
Table 115. Eli Lilly Recent Development
Table 116. Astrazeneca Company Details
Table 117. Astrazeneca Business Overview
Table 118. Astrazeneca Product
Table 119. Astrazeneca Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020) (Million US$)
Table 120. Astrazeneca Recent Development
Table 121. Johnson & Johnson Company Details
Table 122. Johnson & Johnson Business Overview
Table 123. Johnson & Johnson Product
Table 124. Johnson & Johnson Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2015-2020) (Million US$)
Table 125. Johnson & Johnson Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Acyclovir Features
Figure 3. Valacyclovir Features
Figure 4. Famciclovir Features
Figure 5. Others Features
Figure 6. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Varicella-Zoster Virus (VZV) Treatment Report Years Considered
Figure 11. Global Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Players in 2019
Figure 16. Global Top Varicella-Zoster Virus (VZV) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella-Zoster Virus (VZV) Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Varicella-Zoster Virus (VZV) Treatment Revenue in 2019
Figure 18. North America Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

以下、関連資料のご紹介

水痘帯状疱疹感染症治療薬の世界市場（～2026年）

Global Varicella Zoster Infection Treatment Drugs Market Insights and Forecast to 2026
MRC2-11QY12960 2020年11月30日 115Pages
当調査資料は水痘帯状疱疹感染症治療薬のグローバル市場について調査・分析したレポートです。種類別（アシクロビル、バラシクロビル、ファムシクロビル、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...

帯状疱疹感染症治療の世界市場（～2026年）

Global Herpes Zoster Infection Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12180 2020年11月25日 94Pages
当調査資料は帯状疱疹感染症治療のグローバル市場について調査・分析したレポートです。種類別（経口、局所、非経口）市場規模、用途別（クリニック、病院、診断センター、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、...

多形性膠芽腫（GBM）治療の世界市場（～2026年）

Global Glioblastoma Multiforme Treatment (GBM) Market Size, Status and Forecast 2020-2026
MRC2-11QY12056 2020年11月25日 92Pages
当調査資料は多形性膠芽腫（GBM）治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー）市場規模、用途別（ベバコズマブ、カルムスチン、テモゾロミド）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...

グロボイド細胞白質ジストロフィー（GLD）治療の世界市場（～2026年）

Global Globoid Cell Leukodystrophy Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12059 2020年11月25日 93Pages
当調査資料はグロボイド細胞白質ジストロフィー（GLD）治療のグローバル市場について調査・分析したレポートです。種類別（RND-001、CMB-200、DUOC-01、その他）市場規模、用途別（病院、クリニック、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

神経精神障害・治療の世界市場（～2026年）

Global Neuropsychiatric Disorders And Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03957 2020年11月20日 97Pages
当調査資料は神経精神障害・治療のグローバル市場について調査・分析したレポートです。種類別（変性疾患、神経症、精神病）市場規模、用途別（病院、診療所、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オースト...

癲癇診断・治療の世界市場（～2026年）

Global Epilepsy Diagnosis & Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11874 2020年11月25日 91Pages
当調査資料は癲癇診断・治療のグローバル市場について調査・分析したレポートです。種類別（診断（神経学的検査・血液検査・画像診断）、治療（医学・手術））市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

経口血糖降下薬（OAD）治療の世界市場（～2026年）

Global Oral Antidiabetic (OAD) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04077 2020年11月20日 99Pages
当調査資料は経口血糖降下薬（OAD）治療のグローバル市場について調査・分析したレポートです。種類別（スルホニル尿素剤、ビグアニド、腸内α-グルコシダーゼ阻害剤、その他）市場規模、用途別（病院、クリニック、糖尿病治療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、...

髄膜炎診断・治療の世界市場（～2026年）

Global Meningitis Diagnosis and Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12650 2020年11月25日 91Pages
当調査資料は髄膜炎診断・治療のグローバル市場について調査・分析したレポートです。種類別（血液培養、イメージング、腰椎穿刺）市場規模、用途別（病院・クリニック、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド...

HIV診断・治療の世界市場（～2026年）

Global HIV Diagnosis & Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12200 2020年11月25日 95Pages
当調査資料はHIV診断・治療のグローバル市場について調査・分析したレポートです。種類別（ELISA検査、唾液検査、ウイルス量検査、ウエスタンブロット、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

脱毛症（脱毛）治療の世界市場（～2026年）

Global Alopecia (Hair Loss)Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13657 2020年11月30日 95Pages
当調査資料は脱毛症（脱毛）治療のグローバル市場について調査・分析したレポートです。種類別（ビタミン・サプリメント、シャンプー・コンディショナー、その他）市場規模、用途別（男性、女性、子供）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

水痘帯状疱疹感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Varicella Zoster Infection Treatment Drugs Market The global Varicella Zoster Infection Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Varicella Zoster Infection Tr…
帯状疱疹感染症治療の世界市場（～2026年） Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many yea…
エプスタインバーウイルス（HHV-4）感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Epstein-Barr Virus (HHV-4) Infections Treatment Market The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Epstein-Barr Virus …
ヒト免疫不全ウイルス（HIV）の世界市場（～2026年） HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person c…
予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…